• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    RxSight, Inc. - Common Stock (NQ:RXST)

    8.585 -0.205 (-2.33%)
    Streaming Delayed Price Updated: 3:48 PM EST, Nov 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about RxSight, Inc. - Common Stock

    < Previous 1 2
    ...
    5 6 7 8 9 10 11 12 Next >
    RxSight Analysts Slash Their Forecasts After Q2 Results
     
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday! 
    Via InvestorPlace
    Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    RXST Stock Earnings: RxSight Beats Revenue for Q2 2024
    RXST stock results show that RxSight beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    RxSight Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
     
    Via Benzinga
    Why RxSight (RXST) Shares Are Falling
    RxSight shares are trading lower by 5.6% during Thursday's session. The company announced pricing of its $100 million proposed public offering of common stock. 
    Via Benzinga
    What 10 Analyst Ratings Have To Say About RxSight
     
    Via Benzinga
    RxSight, Inc. Reports Second Quarter 2024 Financial Results
    From RxSight, Inc.
    Via GlobeNewswire
    The 3 Best Med Tech Stocks to Buy Now
    Med tech firms are tremendously improving healthcare and making a great deal of money. Here are the three best med tech stocks to buy now. 
    Via InvestorPlace
    RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
    From RxSight, Inc.
    Via GlobeNewswire
    Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
    Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2? 
    Via Benzinga
    Assessing RxSight: Insights From 8 Financial Analysts
     
    Via Benzinga
    Forecasting The Future: 9 Analyst Projections For RxSight
     
    Via Benzinga
    Recap: RxSight Q4 Earnings
     
    Via Benzinga
    Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
     
    Via Benzinga
    RxSight, Inc. To Participate in the Truist Securities Medtech Conference
    From RxSight, Inc.
    Via GlobeNewswire
    Do You Have Your Eye On Vision Care Stocks?
    For investors seeking stable and growing opportunities, eye care stocks are an attractive option. 
    Via Talk Markets
    RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight, Inc. Announces Pricing of Public Offering of Common Stock
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight, Inc. Announces Proposed Public Offering of Common Stock
    From RxSight, Inc.
    Via GlobeNewswire
    RXST Stock Earnings: RxSight Beats EPS, Beats Revenue for Q1 2024
    RXST stock results show that RxSight beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
     
    Via Benzinga
    RxSight, Inc. Reports First Quarter 2024 Financial Results
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight, Inc. to Present at the Bank of America Healthcare Conference
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    From RxSight, Inc.
    Via GlobeNewswire
    Chart Of The Day: RxSight - Cashing In On Cataracts
    Earnings are estimated to increase 33.30% this year, increase an additional 26.60% next year and continue to compound at an annual rate of 19.00% for the next 5 years 
    Via Talk Markets
    RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
    From RxSight, Inc.
    Via GlobeNewswire
    < Previous 1 2
    ...
    5 6 7 8 9 10 11 12 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.